Compile Data Set for Download or QSAR
Report error Found 143 Enz. Inhib. hit(s) with all data for entry = 8675
TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412467(US10399967, Compound 98 | N-(5-(5-ethyl-2-(5-methy...)
Affinity DataIC50: 8nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412475(US10399967, Compound 108 | 5-ethyl-N-(5-(5-ethyl-2...)
Affinity DataIC50: 8nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412392(US10399967, Compound 22 | 5-fluoro-4-methyl-N-(5-(...)
Affinity DataIC50: 9nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412443(US10399967, Compound 73 | 5-bromo-N-(5-(5-ethyl-2-...)
Affinity DataIC50: 9nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412445(US10399967, Compound 75 | N-(5-(2-chloro-5- cyclop...)
Affinity DataIC50: 9nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412441(US10399967, Compound 71 | N-(5-(2-chloro-5- cyclop...)
Affinity DataIC50: 10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412442(US10399967, Compound 72 | 5-chloro-N-(5-(5-ethyl-2...)
Affinity DataIC50: 10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412476(US10399967, Compound 109 | N-(5-(5-ethyl-2-(3-meth...)
Affinity DataIC50: 10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412479(US10399967, Compound 112 | N-(5-(5-ethyl-2-(isoxaz...)
Affinity DataIC50: 10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412489(US10399967, Compound 122 | N-(5-(2-chloro-5-(1-met...)
Affinity DataIC50: 10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412440(US10399967, Compound 70 | N-(5-(5-ethyl-2-(5-methy...)
Affinity DataIC50: 11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412447(US10399967, Compound 77 | N-(5-(5-ethyl-2-(5-methy...)
Affinity DataIC50: 11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412451(US10399967, Compound 81 | 5-bromo-N-(5-(2-chloro-5...)
Affinity DataIC50: 11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412468(US10399967, Compound 99 | 5-fluoro-4-methyl-N-(5-(...)
Affinity DataIC50: 11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412481(US10399967, Compound 114 | 5-chloro-N-(5-(2-chloro...)
Affinity DataIC50: 11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412488(US10399967, Compound 121 | 5-bromo-N-(5-(2-chloro-...)
Affinity DataIC50: 11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412377(US10399967, Compound 7 | N-(5-(2-ethyl-5-(1-methyl...)
Affinity DataIC50: 12nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412387(US10399967, Compound 17 | N-(2'-chloro-5'-(trifluo...)
Affinity DataIC50: 12nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412432(N-(5-(2-chloro-5- cyclopropoxyphenyl)pyrazin-2-yl)...)
Affinity DataIC50: 12nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412384(US10399967, Compound 14 | N-(5-(2-chloro-5-(5-meth...)
Affinity DataIC50: 13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412446(US10399967, Compound 76 | 5-cyano-N-(5-(5-ethyl-2-...)
Affinity DataIC50: 13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412459(US10399967, Compound 90 | N-(5-(2-chloro-5- isopro...)
Affinity DataIC50: 13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412511(US10399967, Compound 144 | N-(5-(2-chloro-5- isopr...)
Affinity DataIC50: 13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412432(N-(5-(2-chloro-5- cyclopropoxyphenyl)pyrazin-2-yl)...)
Affinity DataIC50: 14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412482(US10399967, Compound 115 | N-(5-(2-chloro-5-(1-met...)
Affinity DataIC50: 14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412483(US10399967, Compound 116 | 5-bromo-N-(5-(2-chloro-...)
Affinity DataIC50: 14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412465(US10399967, Compound 136 | (Z)-N-(5-(1-(4-bromophe...)
Affinity DataIC50: 14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412472(US10399967, Compound 103 | (Z)-5-fluoro-N-(5-(1-(4...)
Affinity DataIC50: 16nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412504(US10399967, Compound 137 | N-(5-(2-ethyl-5-((5-met...)
Affinity DataIC50: 17nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412407(US10399967, Compound 37 | N-(5-(2-chloro-5-(2-meth...)
Affinity DataIC50: 18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412463(US10399967, Compound 94 | N-(5-(5-ethyl-2-(5-methy...)
Affinity DataIC50: 18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412473(US10399967, Compound 104 | (Z)-methyl 4-(1-(6-(5-f...)
Affinity DataIC50: 18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412490(US10399967, Compound 123 | N-(5-(2-chloro-5-(1-met...)
Affinity DataIC50: 18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412513(US10399967, Compound 146 | (Z)-N-(5-(1-(4-bromophe...)
Affinity DataIC50: 18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412394(US10399967, Compound 24 | N-(5-(2-chloro-5-(3-fluo...)
Affinity DataIC50: 19nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412376(US10399967, Compound 6 | 5-fluoro-N-(5-(2-methoxy-...)
Affinity DataIC50: 20nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412453(US10399967, Compound 83 | (Z)-N-(5-(1-(4-bromophen...)
Affinity DataIC50: 20nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412498(US10399967, Compound 131 | N-(5-(2-chloro-5-(1-met...)
Affinity DataIC50: 21nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412418(US10399967, Compound 48 | N-(5-(2-ethyl-5-(2-methy...)
Affinity DataIC50: 22nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412423(US10399967, Compound 142 | N-(5-(2-chloro-5-(1-met...)
Affinity DataIC50: 23nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412378(US10399967, Compound 8 | N-(5-(2-ethyl-5-(1-methyl...)
Affinity DataIC50: 25nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412507(US10399967, Compound 140 | (E)-N-(5-(1-(6-ethoxypy...)
Affinity DataIC50: 25nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412396(US10399967, Compound 26 | N-(5-(2-chloro-5-(2-meth...)
Affinity DataIC50: 26nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412397(US10399967, Compound 27 | N-(5-(2-ethyl-5-(2-methy...)
Affinity DataIC50: 26nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412404(US10399967, Compound 34 | N-(5-(2-chloro-5-((6- (t...)
Affinity DataIC50: 26nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412450(US10399967, Compound 80 | N-(5-(2-chloro-5-(1,5-di...)
Affinity DataIC50: 26nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412379(US10399967, Compound 9 | N-(5-(2-chloro-4- cyclopr...)
Affinity DataIC50: 28nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412427(US10399967, Compound 57 | N-(5-(2-chloro-5-(2-meth...)
Affinity DataIC50: 28nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412496(US10399967, Compound 129 | N-(5-(2-chloro-5-(1-met...)
Affinity DataIC50: 30nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

TargetInterleukin-2(Human)
Prcl Research

US Patent
LigandPNGBDBM412403(US10399967, Compound 33 | 4-methyl-N-(5-(2-methyl-...)
Affinity DataIC50: 31nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 143 total ) | Next | Last >>
Jump to: